TMDX
TransMedics Group, Inc.Company Information
- Company Name
- TransMedics Group, Inc.
- CIK
- CIK0001756262
- Category
- Large accelerated filer
- Ticker: Exchange
- TMDX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- TMDX
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-11
- Last sale
- 2026-06-15
- Shares purchased (TTM)
- 10,111
- Shares sold (TTM)
- 38,516
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 34,635,446
- Shares outstanding
- 34,579,980
- Ownership
- 100.16%
Earnings Market Reaction
- Filing date
- 2026-08-04
- Price on filing date
- —
- 1-month reaction
- 9.51%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 473 | 462 | 488 | 466 | 401 | 310 | 337 | 330 | 363 | 350 | 395 | 427 | ||||||
| Accounts Receivable Net Current | 104 | 91 | 84 | 81 | 105 | 142 | 98 | 90 | 81 | 82 | 64 | 61 | ||||||
| Inventory Net | 54 | 50 | 49 | 45 | 39 | 43 | 47 | 52 | 49 | 49 | 44 | 39 | ||||||
| Prepaid Expense And Other Assets Current | 20 | 17 | 16 | 22 | 14 | 10 | 16 | 20 | 17 | 8 | 8 | 10 | ||||||
| Assets Current | 651 | 619 | 638 | 613 | 558 | 506 | 497 | 492 | 509 | 488 | 511 | 537 | ||||||
| Property Plant And Equipment Net | 365 | 362 | 328 | 313 | 312 | 311 | 286 | 272 | 229 | 214 | 174 | 131 | ||||||
| Finance Lease Right Of Use Asset | 332 | 335 | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 | 6 | 6 | 7 | 7 | ||||||
| Deferred Income Tax Assets Net | 79 | 82 | 84 | - | - | - | - | - | - | - | - | - | ||||||
| Restricted Cash Noncurrent | 18 | 18 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Goodwill | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | ||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Other Assets Noncurrent | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 1,464 | 1,435 | 1,068 | 946 | 891 | 838 | 804 | 786 | 759 | 724 | 706 | 689 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 13 | 11 | 10 | 12 | 10 | 11 | 10 | 13 | 13 | 9 | 13 | 13 | ||||||
| Accrued Liabilities And Other Liabilities | 59 | 59 | 63 | 56 | 42 | 40 | 45 | 42 | 38 | 37 | 38 | 32 | ||||||
| Long Term Debt Current | 20 | 15 | 10 | 5 | - | - | - | - | - | - | - | - | ||||||
| Contract With Customer Liability Current | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 3 | ||||||
| Operating Lease Liability Current | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | ||||||
| Liabilities Current | 98 | 92 | 89 | 80 | 57 | 56 | 60 | 60 | 54 | 50 | 55 | 49 | ||||||
| Convertible Debt Noncurrent | 454 | 454 | 453 | 452 | 451 | 451 | 450 | 449 | 449 | 448 | 447 | 446 | ||||||
| Other Long Term Debt Noncurrent | 40 | 45 | 50 | 55 | 60 | 59 | 59 | 59 | 59 | 59 | 59 | 59 | ||||||
| Finance Lease Liability Noncurrent | 348 | 344 | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 2 | 3 | 4 | 4 | 5 | 6 | 6 | 7 | 7 | 7 | 8 | 8 | ||||||
| Other Liabilities Noncurrent | 4 | 4 | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 946 | 941 | 595 | 591 | 572 | 571 | 575 | 576 | 569 | 564 | 569 | 563 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 774 | 765 | 751 | 738 | 726 | 709 | 697 | 685 | 669 | 651 | 641 | 634 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -256 | -271 | -278 | -383 | -408 | -443 | -468 | -475 | -479 | -492 | -504 | -508 | ||||||
| Stockholders Equity | 518 | 494 | 473 | 355 | 318 | 266 | 229 | 210 | 190 | 159 | 137 | 126 | ||||||
| Liabilities And Stockholders Equity | 1,464 | 1,435 | 1,068 | 946 | 891 | 838 | 804 | 786 | 759 | 724 | 706 | 689 | ||||||
| Preferred Stock No Par Value | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock No Par Value | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 35 | 35 | 34 | 34 | 34 | 34 | 34 | 34 | 33 | 33 | 33 | 33 | ||||||
| Shares Outstanding | 35 | 35 | 34 | 34 | 34 | 34 | 34 | 34 | 33 | 33 | 33 | 33 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTransMedics Group, Inc. (TMDX) — SEC Financial Statements & Analysis
TransMedics Group, Inc. (TMDX) is a electromedical & electrotherapeutic apparatus company, incorporated in MA. TransMedics Group, Inc. trades on Nasdaq as: TMDX. TransMedics Group, Inc. (TMDX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04. Based on that filing, TransMedics Group, Inc. carries a market cap of $2.30B, a P/E ratio of 15.14x, a P/B ratio of 4.43x, a P/S ratio of 3.44x, an enterprise value of $2.63B, and an EV/EBITDA multiple of 23.40x. On profitability, it posts a gross margin of 58.69%, an operating margin of 12.21%, a net margin of 22.69%, a Return on Equity (ROE) of 36.28%, a Return on Assets (ROA) of 12.88%, and a Return on Invested Capital (ROIC) of 13.15%. Per share, it reports EPS of $4.39, diluted EPS of $3.73, free cash flow per share of $2.29, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 25.82% year-over-year, net income growth of 111.69% year-over-year, and EPS growth of 107.60% year-over-year. On the balance sheet, it maintains a current ratio of 6.62x, a quick ratio of 5.87x, working capital of $552.84M, a debt-to-equity ratio of 1.83x, a debt ratio of 0.65, an interest coverage ratio of 3.84x, free cash flow of $79.04M (TTM), and net debt of $330.81M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.30B
- P/E TTM
- 15.14x
- EPS TTM
- $4.39
- P/B TTM
- 4.43x
- ROE TTM
- 36.28%
- ROA TTM
- 12.88%
- Debt To Equity
- 1.83x
- Free Cash Flow TTM
- $79.04M
- Net Revenue TTM Growth 1Y
- 25.82%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is TransMedics Group, Inc. in?
TransMedics Group, Inc. (TMDX) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does TMDX trade on?
TransMedics Group, Inc. (TMDX) trades on the Nasdaq.
Where is TransMedics Group, Inc. incorporated?
TransMedics Group, Inc. is incorporated in MA.
When was TransMedics Group, Inc. (TMDX)'s most recent SEC filing?
TransMedics Group, Inc. (TMDX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04.
What is TMDX's market cap?
TransMedics Group, Inc. (TMDX) has a market capitalization of $2.30B as of 2026-06-30.
What is TMDX's P/E ratio?
TransMedics Group, Inc. (TMDX)'s trailing twelve month P/E ratio is 15.14x as of 2026-06-30.
What is TMDX's EPS (earnings per share)?
TransMedics Group, Inc. (TMDX)'s trailing twelve month EPS is $4.39 as of 2026-06-30.
What is TMDX's ROE (return on equity)?
TransMedics Group, Inc. (TMDX)'s trailing twelve month Return on Equity (ROE) is 36.28% as of 2026-06-30.
What is TMDX's ROA (return on assets)?
TransMedics Group, Inc. (TMDX)'s trailing twelve month Return on Assets (ROA) is 12.88% as of 2026-06-30.
What is TMDX's ROIC (return on invested capital)?
TransMedics Group, Inc. (TMDX)'s trailing twelve month Return on Invested Capital (ROIC) is 13.15% as of 2026-06-30.
What is TMDX's EV/EBITDA?
TransMedics Group, Inc. (TMDX)'s trailing twelve month EV/EBITDA is 23.40x as of 2026-06-30.